Cargando…
High-dose fludrocortisone therapy was transiently required in a female neonate with 21-hydroxylase deficiency
For salt-wasting 21-hydroxylase deficiency (21OHD), fludrocortisone (FC) is usually supplemented at 0.05–0.2 mg/d dose. To date, no report has described 21OHD neonates requiring > 0.4 mg/d of FC. Our female 21OHD patient was lethargic and experienced weight loss with hyponatremia (133 mEq/L), hyp...
Autores principales: | Kawasaki, Yusuke, Sato, Takeshi, Nakano, Satsuki, Usui, Takeshi, Narumi, Satoshi, Ishii, Tomohiro, Hasegawa, Tomonobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society for Pediatric Endocrinology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981041/ https://www.ncbi.nlm.nih.gov/pubmed/35431448 http://dx.doi.org/10.1297/cpe.2021-0066 |
Ejemplares similares
-
Functional ovarian cysts in a neonate with classical 21-hydroxylase deficiency: case report and review of the literature
por: Iwayama, Hideyuki, et al.
Publicado: (2013) -
Potential risk of inguinal hernia in complete androgen insensitivity
syndrome
por: Kimizuka, Yu, et al.
Publicado: (2022) -
Transient central diabetes insipidus after cranioplasty for craniosynostosis
in an infant with septo-optic dysplasia
por: Fukuyama, Takahiro, et al.
Publicado: (2021) -
Two girls with a neonatal screening-negative 21-hydroxylase deficiency
requiring treatment with hydrocortisone for virilization in late childhood
por: Onuma, Shinsuke, et al.
Publicado: (2021) -
Fluorodeoxyglucose-positron emission tomography as a potential alternative tool for functional diagnosis of glycogen storage disease type I
por: Sato, Takeshi, et al.
Publicado: (2022)